Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Abelson

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Advances in Therapy|April 3, 2004
Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyesThomas Mundorf, Katrina A Wilcox, George W Ousler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2003
Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge modelMark B Abelson, Matthew J Chapin, Barry M Kapik, et al.
Advances in Experimental Medicine and Biology|March 5, 2003
Alternative reference values for tear film break up time in normal and dry eye populationsMark B Abelson, George W Ousler, Lauren A Nally, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 14, 2013
The interblink interval in normal and dry eye subjectsPatrick R Johnston, John Rodriguez, Keith J Lane, et al.
Cornea|June 4, 2008
The Ocular Protection IndexGeorge W Ousler, Katrina Wilcox Hagberg, Michael Schindelar, et al.
Allergy and Asthma Proceedings|December 10, 2008
A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitisLanny J Rosenwasser, Todd Mahr, Mark B Abelson, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 27, 2013
Investigation of extended blinks and interblink intervals in subjects with and without dry eyeJohn D Rodriguez, George W Ousler, Patrick R Johnston, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 7, 2002
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studiesMark B Abelson, Gregg J Berdy, Thomas Mundorf, et al.
Current Eye Research|December 19, 2007
Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challengeMark B Abelson, Dennis L Spangler, Arthur B Epstein, et al.
Epilepsia|February 21, 2009
Vigabatrin: 2008 updateL James Willmore, Mark B Abelson, Elinor Ben-Menachem, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Advances in Therapy|April 3, 2004
Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyesThomas Mundorf, Katrina A Wilcox, George W Ousler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 14, 2003
Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge modelMark B Abelson, Matthew J Chapin, Barry M Kapik, et al.
Advances in Experimental Medicine and Biology|March 5, 2003
Alternative reference values for tear film break up time in normal and dry eye populationsMark B Abelson, George W Ousler, Lauren A Nally, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 14, 2013
The interblink interval in normal and dry eye subjectsPatrick R Johnston, John Rodriguez, Keith J Lane, et al.
Cornea|June 4, 2008
The Ocular Protection IndexGeorge W Ousler, Katrina Wilcox Hagberg, Michael Schindelar, et al.
Allergy and Asthma Proceedings|December 10, 2008
A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitisLanny J Rosenwasser, Todd Mahr, Mark B Abelson, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 27, 2013
Investigation of extended blinks and interblink intervals in subjects with and without dry eyeJohn D Rodriguez, George W Ousler, Patrick R Johnston, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 7, 2002
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studiesMark B Abelson, Gregg J Berdy, Thomas Mundorf, et al.
Current Eye Research|December 19, 2007
Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challengeMark B Abelson, Dennis L Spangler, Arthur B Epstein, et al.
Epilepsia|February 21, 2009
Vigabatrin: 2008 updateL James Willmore, Mark B Abelson, Elinor Ben-Menachem, et al.
Pageof 7